What Delayed Pharmacy?
The answer likely isn’t because of consumer preferences for physically going to a pharmacy and waiting in line for their script to be filled, or in some cases, being told to come back in an hour. In a Volition Study conducted in April 2020, during the COVID-19 related stay at home mandates, more than 96% of participants who tried pharmacy delivery for the first time said they would likely continue when the quarantine ended.
Partly due to its opaque nature, pharmacy has warranted a different set of expectations relative to other consumer categories. The pharmacy industry is uniquely complex with a web of stakeholders navigating tight regulations to bring appropriate medications into the hands of patients at a low cost. While supply chain dynamics across industries are involved, the flow of money and services in pharmacy is especially difficult to understand.
At the highest level, (1) manufacturers research, develop, and produce drugs, (2) pharmacy benefits managers (PBMs) negotiate prices, (3) wholesalers buy large quantities for distribution, (4) doctors write scripts, (5) pharmacies fill them, (6) insurance companies pay for all or some portion of them, and finally, (7) patients receive their prescriptions…if they receive them.
Alarmingly, as U.S. prescription revenues reached an enormous $446B in 2019, many patients are denied access to doctor-recommended medications, and 20% to 30% of prescriptions are consistently never filled. Gaps in the industry run deeper than delivery, but bringing medications to patients is a sure step in solving the larger adherence problem.